Cytek Biosciences Lowers FY2025 Sales Guidance from $204.00M-$212.00M to $196.00M-$210.00M vs $204.43M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Cytek Biosciences (NASDAQ:CTKB) lowers FY2025 sales outlook from $204.00 million-$212.00 million to $196.00 million-$210.00 million vs $204.43 million estimate.
Cytek Biosciences (NASDAQ:CTKB) lowers FY2025 sales outlook from $204.00 million-$212.00 million to $196.00 million-$210.00 million vs $204.43 million estimate.